Restoring the expression of tumor suppressors, such as PTEN with PPARγ agonists attenuates tumor repopulation, prevents residual tumor cells and aggressivity of tumor cells (86, 91) (Figure 1). The gene discussed is PTEN; the disease is neoplasm.